GLP-Reta 10/30/60MG

Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist studied for its significant effects on weight and metabolic health.

• May support significant and sustained reductions in body weight
• Studied for improvements in blood glucose and insulin sensitivity
• Research suggests benefits in lipid profiles and cardiovascular markers
• Potential role in reducing visceral fat and improving metabolic health

For research purposes only. Not intended for human consumption, veterinary use, or any purpose other than in vitro scientific research. These statements have not been evaluated by the FDA.